Corporate information
Official name
Science 37, Inc.
Company type
Provider of technology enabled clinical research solutions.Funding rounds
Series B USD 31,000,000
USD 31,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
dRx Capital AG | Novartis and Qualcomm joint investment company. | Follow-on investment. Led the round. | |
|
Lux Capital Management LLC | Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences | Follow-on investment. Led the round. | |
|
Sanofi Genzyme BioVentures (SGBV) | The corporate venture capital arm of Sanofi. |
Series A USD 6,500,000
USD 6,500,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
dRx Capital AG | Novartis and Qualcomm joint investment company. | Led the round. | |
|
|
Lux Capital Management LLC | Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences | Led the round. |
Investment activity status
Active investor